Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

Clinical Cancer Research 2026 Open access

Read full text
Authors: Ying Chen, Sandra Catalina Camacho, Thomas R. Silvers, Albiruni RA Razak, Nashat Y. Gabrail, John F. Gerecitano, Eva Kalir, Elena B. Pereira, Brad R. Evans, Susan J. Ramus, Fei Huang, Nolan Priedigkeit
+19 more Estefania Rodriguez, Michael Donovan, Faisal Khan, Tamara Kalir, Robert Sebra, Andrew V. Uzilov, Rong Chen, Rileen Sinha, Richard Halpert, Jean-Noël Billaud, Sharon Shacham, Dilara McCauley, Yosef Landesman, Tami Rashal, Michael G. Kauffman, Mansoor R. Mirza, Morten Mau‐Sørensen, Peter Dottino, John A. Martignetti
DOI: 10.1158/1078-0432.ccr-26-0410
Cited by: 0
References: 1

Fields of Study & Subjects

Nuclear Structure and Function Drug Transport and Resistance Mechanisms Ovarian cancer diagnosis and treatment

Publication details

Journal / source
Clinical Cancer Research
Volume
32
Issue
6
Pages
1183–1183
Publication date
16 March 2026
Language
EN